These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35190423)

  • 1. Strategies prescribers and pharmacists use to identify and mitigate adverse drug reactions in inpatient and outpatient care: a cognitive task analysis at a US Veterans Affairs Medical Center.
    Nguyen KA; Militello LG; Ifeachor A; Arthur KJ; Glassman PA; Zillich AJ; Weiner M; Russ-Jara AL
    BMJ Open; 2022 Feb; 12(2):e052401. PubMed ID: 35190423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: a qualitative, cognitive task analysis.
    Elkhadragy N; Ifeachor AP; Diiulio JB; Arthur KJ; Weiner M; Militello LG; Glassman PA; Zillich AJ; Russ AL
    BMJ Open; 2019 May; 9(5):e027439. PubMed ID: 31129589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care Coordination Strategies and Barriers during Medication Safety Incidents: a Qualitative, Cognitive Task Analysis.
    Russ-Jara AL; Luckhurst CL; Dismore RA; Arthur KJ; Ifeachor AP; Militello LG; Glassman PA; Zillich AJ; Weiner M
    J Gen Intern Med; 2021 Aug; 36(8):2212-2220. PubMed ID: 33479924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive task analysis of clinicians' drug-drug interaction management during patient care and implications for alert design.
    Russ-Jara AL; Elkhadragy N; Arthur KJ; DiIulio JB; Militello LG; Ifeachor AP; Glassman PA; Zillich AJ; Weiner M
    BMJ Open; 2023 Dec; 13(12):e075512. PubMed ID: 38040422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.
    de Vries ST; Denig P; Andrić A; Dimov Di Giusti M; Ptaszynska-Neophytou A; Härmark L; Mol PGM;
    Drug Saf; 2021 Oct; 44(10):1073-1083. PubMed ID: 34368940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
    Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
    Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' experiences on adverse drug reaction: 10 years later.
    Karuppannan M; Mohamad Rizal NAN; Wong KT; Mohd Ali S; Ting KN; Boardman H
    Front Pharmacol; 2022; 13():932942. PubMed ID: 36249772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital.
    Aspinall MB; Whittle J; Aspinall SL; Maher RL; Good CB
    Am J Health Syst Pharm; 2002 May; 59(9):841-5. PubMed ID: 12004462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
    Hussain R; Hassali MA; Hashmi F; Akram T
    J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Avoidance of Adverse Drug Reactions by Pharmacists (Through the PreAVOID Report)].
    Tanigawa K
    Rinsho Byori; 2016 Sep; 64(9):1082-1084. PubMed ID: 30609463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.
    Christ P; Dubrall D; Schmid M; Sachs B
    Drug Saf; 2023 Dec; 46(12):1363-1379. PubMed ID: 37987966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing patient intention to report adverse drug reaction to community pharmacists: A structural equation modeling approach.
    Assanee J; Sorofman BA; Sirisinsuk Y; Kitisopee T
    Res Social Adm Pharm; 2022 Apr; 18(4):2643-2650. PubMed ID: 34039528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning report: a forum for reporting adverse drug reactions.
    Sivaram CA; Johnson S; Tirmizi SN; Robertson V; Garcia D; Sorrells E
    Jt Comm J Qual Improv; 1996 Apr; 22(4):259-63. PubMed ID: 8743062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.